New figures reported by the Company Chemists’ Association (CCA) show that there has been a record net loss of 432 pharmacies in England over the past financial year (2023/24) – an average of more than 8 pharmacies closing each week. Core funding for community pharmacy in England has been cut in real-terms by 30%, having [...]
The post Record loss of 432 pharmacies over the past year appeared first on Community Pharmacy England.
Following the changes to pack sizes for Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension, six more products that require reconstitution have had their pack sizes updated in the NHS dictionary of medicines and devices (dm+d) and the Drug Tariff from May 2024. This follows the identification by Community Pharmacy England of pack size listing discrepancies [...]
The post Products requiring reconstitution – pack size changes appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has today (01/05/2024) confirmed the following final list of price concessions for April 2024. This final update comes after the end of the month and follows the decision by DHSC, under the direction of Ministers, to impose changes to concessions pricing from April to try to manage [...]
The post DHSC’s April 2024 Price Concessions – Final Update appeared first on Community Pharmacy England.
The public is receptive to Pharmacy First but more needs to be done to increase awareness of and further develop pharmacy services, a new report from Healthwatch England finds. The ‘Pharmacy: what people want‘ report, published today (30th April), calls on the Government to issue targeted communications to raise awareness of the Pharmacy First service, [...]
The post Expand and raise awareness of Pharmacy First, says Healthwatch England appeared first on Community Pharmacy England.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment) Montelukast: reminder of the risk of neuropsychiatric reactions Letters [...]
The post MHRA Drug Safety Update: April 2024 appeared first on Community Pharmacy England.
Recent Comments